These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17654028

  • 1. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion.
    Zheng X, Yang R, Tang X, Zheng L.
    Drug Dev Ind Pharm; 2007 Jul; 33(7):791-802. PubMed ID: 17654028
    [Abstract] [Full Text] [Related]

  • 2. Part II: bioavailability in beagle dogs of nimodipine solid dispersions prepared by hot-melt extrusion.
    Zheng X, Yang R, Zhang Y, Wang Z, Tang X, Zheng L.
    Drug Dev Ind Pharm; 2007 Jul; 33(7):783-9. PubMed ID: 17654027
    [Abstract] [Full Text] [Related]

  • 3. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A.
    Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284
    [Abstract] [Full Text] [Related]

  • 4. Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion.
    Jijun F, Lishuang X, Xiaoli W, Shu Z, Xiaoguang T, Xingna Z, Haibing H, Xing T.
    Drug Dev Ind Pharm; 2011 Aug 20; 37(8):934-44. PubMed ID: 21417606
    [Abstract] [Full Text] [Related]

  • 5. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.
    Sun Y, Rui Y, Wenliang Z, Tang X.
    Int J Pharm; 2008 Jul 09; 359(1-2):144-9. PubMed ID: 18499371
    [Abstract] [Full Text] [Related]

  • 6. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K, Sawicki W, Haber K, Knapik J, Wojnarowska Z, Paluch M, Lepek P, Hawelek L, Tajber L.
    Eur J Pharm Biopharm; 2015 Aug 09; 94():106-15. PubMed ID: 25998701
    [Abstract] [Full Text] [Related]

  • 7. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
    Zhao M, Barker SA, Belton PS, McGregor C, Craig DQ.
    Eur J Pharm Biopharm; 2012 Nov 09; 82(3):572-9. PubMed ID: 22922419
    [Abstract] [Full Text] [Related]

  • 8. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.
    Zhang Y, Luo R, Chen Y, Ke X, Hu D, Han M.
    AAPS PharmSciTech; 2014 Jun 09; 15(3):560-8. PubMed ID: 24570374
    [Abstract] [Full Text] [Related]

  • 9. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
    Chokshi RJ, Sandhu HK, Iyer RM, Shah NH, Malick AW, Zia H.
    J Pharm Sci; 2005 Nov 09; 94(11):2463-74. PubMed ID: 16200544
    [Abstract] [Full Text] [Related]

  • 10. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F, Kang A, Shan J, Zhao X, Bi X, Li J, Di L.
    Int J Pharm; 2014 Apr 25; 465(1-2):436-43. PubMed ID: 24576810
    [Abstract] [Full Text] [Related]

  • 11. Effect of HPMCAS on recrystallization inhibition of nimodipine solid dispersions prepared by hot-melt extrusion and dissolution enhancement of nimodipine tablets.
    Zhang Q, Zhao Y, Zhao Y, Ding Z, Fan Z, Zhang H, Liu M, Wang Z, Han J.
    Colloids Surf B Biointerfaces; 2018 Dec 01; 172():118-126. PubMed ID: 30144623
    [Abstract] [Full Text] [Related]

  • 12. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S, O'Donnell KP, Keen JM, Rickard MA, McGinity JW, Williams RO.
    AAPS PharmSciTech; 2016 Feb 01; 17(1):106-19. PubMed ID: 26335416
    [Abstract] [Full Text] [Related]

  • 13. The inhibition effect of high storage temperature on the recrystallization rate during dissolution of nimodipine-Kollidon VA64 solid dispersions (NM-SD) prepared by hot-melt extrusion.
    Jijun F, Lishuang X, Xiaoguang T, Min S, Mingming Z, Haibing H, Xing T.
    J Pharm Sci; 2011 May 01; 100(5):1643-7. PubMed ID: 21374603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN, Vemavarapu C, Lodaya M.
    Int J Pharm; 2007 Jan 10; 328(2):119-29. PubMed ID: 16968659
    [Abstract] [Full Text] [Related]

  • 17. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I, Snyder J, Vippagunta R, Alvine M, Vakil R, Tong WQ, Vippagunta S.
    Int J Pharm; 2011 Oct 31; 419(1-2):12-9. PubMed ID: 21782911
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN, Vemavarapu C, Lodaya M.
    Pharm Res; 2006 Aug 31; 23(8):1928-36. PubMed ID: 16871443
    [Abstract] [Full Text] [Related]

  • 20. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
    Qian F, Wang J, Hartley R, Tao J, Haddadin R, Mathias N, Hussain M.
    Pharm Res; 2012 Oct 31; 29(10):2765-76. PubMed ID: 22315020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.